The ALS prevalence is expected to rise across multiple nations by 2040 due to aging populations and increased ALS survival ...
AbbVie and Calico first inked their partnership in 2014 with up to $1.5 billion in funding to advance therapies for diseases, ...
Diagnosed with A.L.S., they traded stories, drank tequila and made grim jokes at a unique annual gathering on Cape Cod.
Researcher Melissa Schilling said that she was "surprised to find such a strong geographic pattern" in the U.S. distribution ...
Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to ...
Inflammasome Therapeutics ( a clinical-stage biotech company developing a new class of drugs, Kamuvudines, for ophthalmic and neurological conditions, announced the company has signed a contract with ...
Although amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). are very different diseases, they have ...
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurological disorder causing motor neuron death, leading to muscle ...
Researchers in Germany say combining two blood biomarkers may make the diagnosis of ALS more accurate and help predict disease progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback